These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3825497)

  • 1. Prognostic indicators in multiple sclerosis.
    Poser S; Poser W; Schlaf G; Firnhaber W; Lauer K; Wolter M; Evers P
    Acta Neurol Scand; 1986 Nov; 74(5):387-92. PubMed ID: 3825497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival in disseminated sclerosis in Denmark. A nation-wide study of the period 1948-1986].
    Brønnum-Hansen H; Koch-Henriksen NJ; Hyllested K
    Ugeskr Laeger; 1995 Dec; 157(51):7131-5. PubMed ID: 8545927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey.
    Brønnum-Hansen H; Koch-Henriksen N; Hyllested K
    Neurology; 1994 Oct; 44(10):1901-7. PubMed ID: 7936244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
    Phadke JG
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):523-31. PubMed ID: 3495637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort.
    Rollot F; Fauvernier M; Uhry Z; Vukusic S; Bossard N; Remontet L; Leray E;
    Neurology; 2021 Jul; 97(4):e403-e413. PubMed ID: 34011577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
    Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
    Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in multiple sclerosis.
    Poser S; Kurtzke JF; Poser W; Schlaf G
    J Clin Epidemiol; 1989; 42(2):159-68. PubMed ID: 2918325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of multiple sclerosis in Finland between 1964 and 1993.
    Sumelahti ML; Tienari PJ; Wikström J; Salminen TM; Hakama M
    Mult Scler; 2002 Aug; 8(4):350-5. PubMed ID: 12166507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
    Leray E; Vukusic S; Debouverie M; Clanet M; Brochet B; de Sèze J; Zéphir H; Defer G; Lebrun-Frenay C; Moreau T; Clavelou P; Pelletier J; Berger E; Cabre P; Camdessanché JP; Kalson-Ray S; Confavreux C; Edan G
    PLoS One; 2015; 10(7):e0132033. PubMed ID: 26148099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).
    Kantarci O; Siva A; Eraksoy M; Karabudak R; Sütlaş N; Ağaoğlu J; Turan F; Ozmenoğlu M; Toğrul E; Demirkiran M
    Neurology; 1998 Sep; 51(3):765-72. PubMed ID: 9748024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological investigations into multiple sclerosis in Southern Hesse. V. Course and prognosis.
    Lauer K; Firnhaber W
    Acta Neurol Scand; 1987 Jul; 76(1):12-7. PubMed ID: 3498287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study.
    Koch-Henriksen N; Laursen B; Stenager E; Magyari M
    J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):626-631. PubMed ID: 28705951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: disability and mortality in a cohort of clinically diagnosed patients.
    Citterio A; Azan G; Bergamaschi R; Erbetta A; Cosi V
    Neuroepidemiology; 1989; 8(5):249-53. PubMed ID: 2530458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models.
    Riise T; Grønning M; Aarli JA; Nyland H; Larsen JP; Edland A
    J Clin Epidemiol; 1988; 41(10):1031-6. PubMed ID: 3193137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in survival and cause of death in Danish patients with multiple sclerosis.
    Brønnum-Hansen H; Koch-Henriksen N; Stenager E
    Brain; 2004 Apr; 127(Pt 4):844-50. PubMed ID: 14960501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disability and mortality in a cohort of multiple sclerosis patients: a reappraisal.
    Bergamaschi R; Montomoli C; Candeloro E; Fratti C; Citterio A; Cosi V
    Neuroepidemiology; 2005; 25(1):15-8. PubMed ID: 15855800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple sclerosis mortality in Poland].
    Cendrowski W
    Neurol Neurochir Pol; 1986; 20(5):444-7. PubMed ID: 3587514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival in multiple sclerosis.
    Lević ZM; Dujmović I; Pekmezović T; Jarebinski M; Marinković J; Stojsavljević N; Drulović J
    Mult Scler; 1999 Jun; 5(3):171-8. PubMed ID: 10408717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.
    Confavreux C; Aimard G; Devic M
    Brain; 1980 Jun; 103(2):281-300. PubMed ID: 7397479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.